<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. حسب Hala Tamim El Jarkass (16625309)

الموضوعات:

Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. حسب Mucahit Gemici (21519313)

One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. حسب Mucahit Gemici (21519313)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

PRISMA flow chart. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical efficacy of relevant PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. حسب Filip Stanicic (17808254)

الموضوعات:

Addressing the Gap in Oncologist Training حسب Skylar Gay (20696057)

"…</p><p dir="ltr"><b>Results</b>: The algorithms successfully created radiotherapy dose distributions with decreased organs-at-risk sparing, decreased target conformality, and increased hotspots that were statistically significant (p<0.05) when assessed by dose-volume histogram metrics. …"

ROC curves for hub genes. حسب Jiyong Zhang (2498740)

الموضوعات:

Test soil parameters. حسب Yonggang Huang (223155)

الموضوعات:

Differences in immune infiltration between NAFLD and control groups. حسب Jiyong Zhang (2498740)

الموضوعات: